Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

p53 mutations promote proteasomal activity

Subjects

p53 mutations occur very frequently in human cancer. Besides abrogating the tumour suppressive functions of wild-type p53, many of those mutations also acquire oncogenic gain-of-function activities. Augmentation of proteasome activity is now reported as a common gain-of-function mechanism shared by different p53 mutants, which promotes cancer resistance to proteasome inhibitors.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Molecular mechanisms mediating mutant p53 gain-of-function.

References

  1. Olivier, M. & Taniere, P. Curr. Opin. Oncol. 23, 88–92 (2011).

    Article  CAS  Google Scholar 

  2. Rotter, V. Proc. Natl Acad. Sci. USA 80, 2613–2617 (1983).

    Article  CAS  Google Scholar 

  3. Oren, M. & Rotter, V. Cold Spring Harb. Perspect. Biol. 2, a001107 (2010).

    Article  Google Scholar 

  4. Freed-Pastor, W. A. & Prives, C. Genes Dev. 26, 1268–1286 (2012).

    Article  CAS  Google Scholar 

  5. Kato, S. et al. Proc. Natl Acad. Sci. USA 100, 8424–8429 (2003).

    Article  CAS  Google Scholar 

  6. Zhu, J. et al. Nature 525, 206–211 (2015).

    Article  CAS  Google Scholar 

  7. Walerych, D. et al. Nat. Cell Biol. 18, 897–909 (2016).

    Article  CAS  Google Scholar 

  8. DeNicola, G. M. et al. Nature 475, 106–109 (2011).

    Article  CAS  Google Scholar 

  9. Tung, M. C. et al. Oncotarget 6, 41692–41705 (2015).

    PubMed  PubMed Central  Google Scholar 

  10. Hershko, A. & Ciechanover, A. Annu. Rev. Biochem. 67, 425–479 (1998).

    Article  CAS  Google Scholar 

  11. Vogelstein, B. et al. Science 339, 1546–1558 (2013).

    Article  CAS  Google Scholar 

  12. Deshaies, R. J. BMC Biol. 12, 94 (2014).

    Article  Google Scholar 

  13. Richardson, P. G. et al. N. Engl. J. Med. 352, 2487–2498 (2005).

    Article  CAS  Google Scholar 

  14. O'Connor, O. A. et al. J. Clin. Oncol. 23, 676–684 (2005).

    Article  CAS  Google Scholar 

  15. Brosh, R. & Rotter, V. Nat. Rev. Cancer 9, 701–713 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Moshe Oren or Eran Kotler.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oren, M., Kotler, E. p53 mutations promote proteasomal activity. Nat Cell Biol 18, 833–835 (2016). https://doi.org/10.1038/ncb3392

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb3392

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer